Project Grant R01DA060193
Award Date 9/1/25
Completion Date 5/31/30
Dollars Obligated $798K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
- This $139,457 Project Grant award, issued by the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs), supports a research project at the University of Oklahoma Health Sciences Center (OUHSC). The project aims to: Evaluate the role of depressive symptoms on smoking cessation and treatment mechanisms using a Just-In-Time Adaptive Intervention (JITAI) approach. This will examine how treatment mechanisms vary between adults with and without elevated depressive...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a multi-method study on momentary distress intolerance and its relationship to cigarette smoking among adults with emotional distress. The $233,913 award to Rutgers, The State University will fund a 5-year research plan involving qualitative investigation, ecological momentary assessment, and longitudinal modeling to better understand...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $823,882 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Oregon Health & Science University (OHSU) on July 15, 2025. The TEAM-UP: Tobacco Treatment Navigators Uniting with Primary Care project aims to implement and compare two outreach strategies, a person-based Outreach Navigator (ON) and a technology-based Interactive Patient Portal (IPP), to improve...
- This Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) aims to develop machine learning approaches to personalize cigarette smoking risk prediction for adults trying to quit smoking. The $200,676 award supports research to identify dynamic patterns and key features that predict smoking lapses and relapses during quit attempts, in order to inform the development of personalized smoking cessation interventions and clinical...
- This federal Project Grant award, funded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research), is focused on developing a cue-based smoking cessation intervention delivered via telehealth for people who smoke lightly (PSLI). The $906,306 award, with a performance period from September 2025 to August 2028, aims to adapt and pilot test an intervention that combines cue-based treatment with standard cognitive behavioral therapy (CBT) to promote smoking cessation...
- This federal Project Grant award of $742,500 from the National Institute on Drug Abuse (NIDA), which is part of the Drug Use and Addiction Research Programs (CFDA 93.279), supports research on a peer recovery coaching intervention to promote tobacco abstinence among individuals with opioid use disorder. The award will fund a 3-year pilot study to adapt a behavioral tobacco use disorder (TUD) intervention called PEERTTS for people with opioid use disorder and TUD, and to train peer recovery...
- This $674,709 Project Grant awarded on July 15, 2025 by the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), supports research aimed at understanding the neural mechanisms underlying the effects of continuous theta burst stimulation (cTBS) on inhibitory control and craving regulation in nicotine addiction. The research, conducted by the University of Missouri System, involves a location control crossover study examining how cTBS...
- This $105,076 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the neurocomputational basis of effort-based decision making (EBDM) in individuals with tobacco use disorder, tobacco and opioid use disorder, and healthy controls. The award will support research to characterize the neurocomputational basis of EBDM during a smoking cessation attempt. The project will computationally model...
- This Project Grant award, funded by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research on the "Addiction Potential, Flavoring Content, and Substitutability of Concept Flavored Cigarillos." The $752,701 award, with a performance period from August 1, 2025 to May 31, 2030, will be conducted by the University of Oklahoma Health Sciences Center (OUHSC). The research aims to investigate the addiction...
- The federal Project Grant award titled "NEUROMARKERS FOR CRAVING AND DRUG USE" is funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $800,617 grant, awarded on June 1, 2025, supports the development and validation of neuromarkers - measurable, brain-based indicators of pathophysiology, risk, and resilience related to substance use disorders. The research, conducted by the University of California, Berkeley, aims...